Drug profile · INN
imiglucerase
CEREZYME
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
imiglucerase (CEREZYME) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN imiglucerase
Brand CEREZYME
Route INJECTION
Formulation INJECTABLE
ATC code A16AB02
Frequently asked questions
What is imiglucerase?
imiglucerase (CEREZYME) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for imiglucerase?
CEREZYME is a marketed brand name for imiglucerase. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of imiglucerase?
imiglucerase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.